Logo image of CHSCM

CHS INC - CHSINC 6 3/4 PERP (CHSCM) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:CHSCM - US12542R7044

25 USD
0 (0%)
Last: 11/21/2025, 8:18:17 PM
Fundamental Rating

3

Taking everything into account, CHSCM scores 3 out of 10 in our fundamental rating. CHSCM was compared to 87 industry peers in the Food Products industry. While CHSCM is still in line with the averages on profitability rating, there are concerns on its financial health. CHSCM has a expensive valuation and it also scores bad on growth. CHSCM also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year CHSCM had a positive cash flow from operations.
Each year in the past 5 years CHSCM has been profitable.
In the past 5 years CHSCM always reported a positive cash flow from operatings.
CHSCM Yearly Net Income VS EBIT VS OCF VS FCFCHSCM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

1.2 Ratios

With a Return On Assets value of 2.61%, CHSCM perfoms like the industry average, outperforming 56.32% of the companies in the same industry.
With a Return On Equity value of 4.76%, CHSCM perfoms like the industry average, outperforming 52.87% of the companies in the same industry.
CHSCM has a Return On Invested Capital (0.05%) which is in line with its industry peers.
CHSCM had an Average Return On Invested Capital over the past 3 years of 6.11%. This is significantly below the industry average of 28.38%.
The 3 year average ROIC (6.11%) for CHSCM is well above the current ROIC(0.05%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 2.61%
ROE 4.76%
ROIC 0.05%
ROA(3y)8.28%
ROA(5y)6.12%
ROE(3y)15.4%
ROE(5y)11.43%
ROIC(3y)6.11%
ROIC(5y)4.27%
CHSCM Yearly ROA, ROE, ROICCHSCM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 1.42%, CHSCM is in line with its industry, outperforming 50.57% of the companies in the same industry.
In the last couple of years the Profit Margin of CHSCM has grown nicely.
CHSCM has a Operating Margin of 0.02%. This is comparable to the rest of the industry: CHSCM outperforms 41.38% of its industry peers.
In the last couple of years the Operating Margin of CHSCM has declined.
CHSCM's Gross Margin of 2.99% is on the low side compared to the rest of the industry. CHSCM is outperformed by 86.21% of its industry peers.
CHSCM's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 0.02%
PM (TTM) 1.42%
GM 2.99%
OM growth 3Y40.55%
OM growth 5Y-6.01%
PM growth 3Y24.89%
PM growth 5Y1.53%
GM growth 3Y21.71%
GM growth 5Y0.55%
CHSCM Yearly Profit, Operating, Gross MarginsCHSCM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1 2 3 4 5

3

2. Health

2.1 Basic Checks

CHSCM has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
CHSCM has a worse debt/assets ratio than last year.
CHSCM Yearly Shares OutstandingCHSCM Yearly Shares OutstandingYearly Shares Outstanding 2018 2M 4M 6M 8M 10M
CHSCM Yearly Total Debt VS Total AssetsCHSCM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

An Altman-Z score of 2.22 indicates that CHSCM is not a great score, but indicates only limited risk for bankruptcy at the moment.
CHSCM has a Altman-Z score (2.22) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.34 indicates that CHSCM is not too dependend on debt financing.
The Debt to Equity ratio of CHSCM (0.34) is better than 60.92% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF N/A
Altman-Z 2.22
ROIC/WACC0.01
WACC4.68%
CHSCM Yearly LT Debt VS Equity VS FCFCHSCM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

A Current Ratio of 1.40 indicates that CHSCM should not have too much problems paying its short term obligations.
With a Current ratio value of 1.40, CHSCM perfoms like the industry average, outperforming 45.98% of the companies in the same industry.
CHSCM has a Quick Ratio of 1.40. This is a bad value and indicates that CHSCM is not financially healthy enough and could expect problems in meeting its short term obligations.
CHSCM has a Quick ratio (0.86) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.4
Quick Ratio 0.86
CHSCM Yearly Current Assets VS Current LiabilitesCHSCM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

1

3. Growth

3.1 Past

The Revenue has decreased by -8.96% in the past year.
Measured over the past years, CHSCM shows a small growth in Revenue. The Revenue has been growing by 4.24% on average per year.
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-8.96%
Revenue growth 3Y0.7%
Revenue growth 5Y4.24%
Sales Q2Q%1.63%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CHSCM Yearly Revenue VS EstimatesCHSCM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

1

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
CHSCM Price Earnings VS Forward Price EarningsCHSCM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

95.40% of the companies in the same industry are more expensive than CHSCM, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.75
CHSCM Per share dataCHSCM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 500 1K 1.5K 2K 2.5K

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.47%, CHSCM is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 5.15, CHSCM pays a better dividend. On top of this CHSCM pays more dividend than 89.66% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.45, CHSCM pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.47%

5.2 History

CHSCM has paid a dividend for at least 10 years, which is a reliable track record.
CHSCM has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years4
CHSCM Yearly Dividends per shareCHSCM Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

32.94% of the earnings are spent on dividend by CHSCM. This is a low number and sustainable payout ratio.
DP32.94%
EPS Next 2YN/A
EPS Next 3YN/A
CHSCM Yearly Income VS Free CF VS DividendCHSCM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B
CHSCM Dividend Payout.CHSCM Dividend Payout, showing the Payout Ratio.CHSCM Dividend Payout.PayoutRetained Earnings

CHS INC - CHSINC 6 3/4 PERP

NASDAQ:CHSCM (11/21/2025, 8:18:17 PM)

25

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)11-04 2025-11-04
Earnings (Next)01-06 2026-01-06
Inst Owners11.67%
Inst Owner Change31.41%
Ins Owners0.03%
Ins Owner Change0%
Market Cap306.75M
Revenue(TTM)36.03B
Net Income(TTM)513.00M
Analysts0
Price TargetN/A
Short Float %0.07%
Short Ratio0.38
Dividend
Industry RankSector Rank
Dividend Yield 7.47%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP32.94%
Div Incr Years0
Div Non Decr Years4
Ex-Date12-16 2025-12-16 (0.421875)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF N/A
P/OCF 0.64
P/B 0.03
P/tB 0.03
EV/EBITDA 3.75
EPS(TTM)N/A
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-26.32
FCFYN/A
OCF(TTM)38.96
OCFY155.83%
SpS2936.43
BVpS878.97
TBVpS878.97
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 2.61%
ROE 4.76%
ROCE 0.07%
ROIC 0.05%
ROICexc 0.05%
ROICexgc 0.05%
OM 0.02%
PM (TTM) 1.42%
GM 2.99%
FCFM N/A
ROA(3y)8.28%
ROA(5y)6.12%
ROE(3y)15.4%
ROE(5y)11.43%
ROIC(3y)6.11%
ROIC(5y)4.27%
ROICexc(3y)6.66%
ROICexc(5y)4.61%
ROICexgc(3y)6.79%
ROICexgc(5y)4.69%
ROCE(3y)8.06%
ROCE(5y)5.71%
ROICexgc growth 3Y38.36%
ROICexgc growth 5Y-3.28%
ROICexc growth 3Y37.82%
ROICexc growth 5Y-3.23%
OM growth 3Y40.55%
OM growth 5Y-6.01%
PM growth 3Y24.89%
PM growth 5Y1.53%
GM growth 3Y21.71%
GM growth 5Y0.55%
F-Score3
Asset Turnover1.83
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF N/A
Debt/EBITDA 5.94
Cap/Depr 131.31%
Cap/Sales 2.22%
Interest Coverage 250
Cash Conversion 77.22%
Profit Quality N/A
Current Ratio 1.4
Quick Ratio 0.86
Altman-Z 2.22
F-Score3
WACC4.68%
ROIC/WACC0.01
Cap/Depr(3y)104.21%
Cap/Depr(5y)89.6%
Cap/Sales(3y)1.35%
Cap/Sales(5y)1.27%
Profit Quality(3y)93.36%
Profit Quality(5y)103.6%
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-8.96%
Revenue growth 3Y0.7%
Revenue growth 5Y4.24%
Sales Q2Q%1.63%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-98.83%
EBIT growth 3Y41.53%
EBIT growth 5Y-2.03%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-109.49%
FCF growth 3Y1.79%
FCF growth 5Y-7.81%
OCF growth 1Y-87.82%
OCF growth 3Y18.88%
OCF growth 5Y2.23%

CHS INC - CHSINC 6 3/4 PERP / CHSCM FAQ

What is the ChartMill fundamental rating of CHS INC - CHSINC 6 3/4 PERP (CHSCM) stock?

ChartMill assigns a fundamental rating of 3 / 10 to CHSCM.


What is the valuation status for CHSCM stock?

ChartMill assigns a valuation rating of 1 / 10 to CHS INC - CHSINC 6 3/4 PERP (CHSCM). This can be considered as Overvalued.


Can you provide the profitability details for CHS INC - CHSINC 6 3/4 PERP?

CHS INC - CHSINC 6 3/4 PERP (CHSCM) has a profitability rating of 4 / 10.


How financially healthy is CHS INC - CHSINC 6 3/4 PERP?

The financial health rating of CHS INC - CHSINC 6 3/4 PERP (CHSCM) is 3 / 10.


How sustainable is the dividend of CHS INC - CHSINC 6 3/4 PERP (CHSCM) stock?

The dividend rating of CHS INC - CHSINC 6 3/4 PERP (CHSCM) is 7 / 10 and the dividend payout ratio is 32.94%.